Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …

Background Xpert MTB/RIF and Xpert MTB/RIF Ultra (Xpert Ultra) are World Health
Organization (WHO)‐recommended rapid tests that simultaneously detect tuberculosis and …

Aim To evaluate the sensitivity, specificity, positive predictive value and negative predictive
value of Nucleic acid amplification assay (GeneXpert) using respiratory samples in patients …

Pulmonary tuberculosis still remains a major communicable disease worldwide. In 2013, 9
million people developed TB and 1.5 million people died from the disease. India constitutes …

Background Fiberoptic bronchoscopy (FOB) is a useful diagnosis tool in low-burden
countries for patients with suspected pulmonary tuberculosis (TB) who are smear-negative …

Tuberculosis (TB) is one of the leading causes of morbidity and mortality worldwide. Early
diagnosis and treatment are key to prevent Mycobacterium tuberculosis transmission …

Objective: To measure the diagnostic yield of Bronchoalveolar Lavage (BAL) gene Xpert
(Xpert MTB/RIF assay), to detect Mycobacterium tuberculosis (MTB) and rifampicin …

Background To estimate the diagnostic accuracy of Xpert MTB/RIF for rifampicin resistance
in different regions, a meta-analysis was carried out. Methods Several databases were …

The recognition that drug-resistant tuberculosis (DR-TB) poses a major threat to global
tuberculosis (TB) control efforts has catalysed the development of new and urgently needed …

Abstract Background Xpert MTB/RIF has been shown to have a superior sensitivity to
microscopy for acid fast bacilli (AFB) in sputum and has been recommended as a standard …